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BACKGROUND: Gastric fundal atrophy has been hypothesised to increase the risk of oesophageal squamous cell carcinoma (OSCC),
but studies have shown inconsistent results.
METHODS: We measured serum pepsinogen I (PGI) and pepsinogen II (PGII) among 293 incident cases and 524 matched
neighbourhood controls in a high-risk area of Northern Iran. Conditional logistic regression model was used to estimate odds ratios
(ORs) and their 95% confidence intervals (CIs).
RESULTS: After controlling for age, sex, residence area and other potential confounders, gastric atrophy (defined by a validated
criterion, PGIo55mg dl 1) was associated with a two-fold increased risk (OR¼ 2.01, 95% CI: 1.18, 3.45) of OSCC in the absence of
nonatrophic pangastritis (defined as PGII o11.8mg dl 1). Stratification by PGII decreased the misclassification errors due to cancer-
induced gastritis. Presence of both poor dental health, indicated by higher than median sum of decayed, missing, and filled teeth
(DMFT score), and gastric atrophy further increased the risk of OSCC (OR¼ 4.15, 95% CI: 2.04, 8.42) with relative excess risk due to
interaction (RERI) of 1.47 (95% CI:  1.15, 4.1). Coexistence of poor oral hygiene habit with gastric atrophy elevated OSCC risk
eight times (OR¼ 8.65, 95% CI: 3.65, 20.46) and the additive interaction index was marginally statistically significant (RERI¼ 4.34,
95% CI:  1.07, 9.76).
CONCLUSION: Gastric atrophy is a risk factor for OSCC, and poor dental health and oral hygiene habit may act synergistically in
increasing the risk.
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Oesophageal cancer is the eighth most common cause of cancer
death worldwide (Jemal et al, 2011). Gastric atrophy as a
consequence of chronic Helicobacter pylori infection was linked
to an increased risk of oesophageal squamous cell carcinoma
(OSCC) in a Swedish population-based case–control study
(Ye et al, 2004). In the atrophic stomach, hypochlorohydria allows
bacterial overgrowth (Viani et al, 2000) and may produce potential
carcinogenic substances, such as nitrosamines, which are also
related to alcohol drinking and tobacco smoking (Millonig et al,
2011). Histology is the gold standard for diagnosing gastric
atrophy. However, because of its inconvenience in large epide-
miological studies, serum level of pepsinogens has been applied as
a replacement method. Pepsinogen I (PGI) is produced in the
fundic glands and decreases proportionally with progression of
fundic atrophy. Pepsinogen II (PGII) is synthesised in most
parts of the gastric mucosa and part of the duodenum and some
studies have shown its importance in detecting inflammation
(He et al, 2011) or gastric cancer screening (Abnet et al, 2011).
Magnitude of the reported associations between serological
gastric atrophy and OSCC varied from null to eightfold (Iijima
et al, 2007; de Vries et al, 2009; Ren et al, 2009; Cook et al, 2010;
Venerito et al, 2011).
Poor oral and dental hygiene are also linked to nitrosamine
(Meurman and Uittamo, 2008) and acetaldehyde production
(National Toxicology Program, 2010). In addition, poor oral
hygiene and dental health have been shown to be associated with
an increased risk of OSCC in high-risk areas (Abnet et al, 2001,
2008). Previous studies have not tested possible synergism between
these two risk factors. Golestan province in Iran is located in the
Asian Oesophageal Cancer Belt and has some of the highest
incidence rates for OSCC (Mahboubi et al, 1973; Saidi et al, 2000).
Unlike low-risk areas, tobacco and alcohol use are not major risk
factors for OSCC in this belt (Nasrollahzadeh et al, 2008), from
which 90% of the OSCC cases arise worldwide. We evaluated
the association between gastric atrophy (measured by serum
pepsinogen level) and OSCC in a population-based case–control
study in Northern Iran and tested joint effect on OSCC risk in the
presence of both gastric atrophy and poor oral hygiene.
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MATERIALS AND METHODS
Case and control selection
Details of subject selection have been reported earlier
(Nasrollahzadeh et al, 2008). Briefly, case subjects were recruited
at Atrak clinic, the only specialised clinic for oesophageal cancer
diagnosis and treatment in eastern Golestan, from December 2003
to June 2007. Included cases were those of histopathologically
confirmed OSCC patients who underwent oesophago-gastro-
duodenal videoscopy at Atrak clinic and agreed to participate in
the study. The reports of the local cancer registry demonstrated
that B70% of all incident cases during the study period were
referred to Atrak clinic (unpublished data). Attempts were made to
select two population-based control subjects, individually matched
to the cases by age (±2 years), sex, and from the same
neighbourhood or village using annually updated family health
census. List of all potentially eligible controls for rural cases was
ordered randomly in each village and for urban cases was ordered
by geographic proximity to the case’s residence. In all, 77% of the
enrolled controls were the first selected neighbours, and 11% and
3%, respectively, were the second and third choices from the lists.
Absence of the eligible control at the time of invitation was almost
always the reason for not participating in the study. In total, we
recruited 300 cases and 571 matched controls.
To investigate whether OSCC cases have higher risk of
developing non-atrophic gastritis in histology, we used another
set of controls. Controls were consisted of endoscopy room
patients who were referred to Atrak clinic with a suspicion of
upper gastrointestinal malignancies during same period of case
enrolment and were matched for age and sex. Three biopsy tissues
from lesser-curvature antrum, lesser-curvature body and cardia
were available for 261 cases (88%) and 274 controls.
Interview and examination
After obtaining written informed consent from each subject,
a nurse and a physician administered a structured questionnaire.
A nutritionist administered a validated food frequency questionnaire
(Malekshah et al, 2006). All interviews were conducted face to face
at Atrak clinic for case subjects and at health centres for controls
except those chosen from Gonbad city who were interviewed at
Golestan Cohort Centre. No proxies were used.
The trained physicians examined each patient’s oral cavity and
teeth. Number of decayed, missing, and filled teeth (DMFT score)
in addition to frequency of tooth brushing was recorded.
Detailed information has been published elsewhere (Abnet et al,
2008). Reliability of measuring tooth count using k statistic was
0.86 (Pourshams et al, 2005). Data was collected on demographic
variables, ethnicity, alcohol consumption, lifelong history of
tobacco or opium use, medication, and several potential
confounders.
Serological data
Prior to endoscopy, an experienced nurse collected 12ml venous
blood sample from each case subject. A trained technician
immediately separated serum and stored it at  80 1C. Collected
blood samples from matched controls were transferred on ice in a
cooler box (B4 1C). Time between collection and processing of
neighbourhood control samples was o12 h. For those controls
who were interviewed at the Golestan Cohort Centre, sample
processing and storage were performed immediately. Samples were
transported on dry ice to Karolinska Institutet, Sweden, and stored
at  20 1C prior to analysis. Serum pepsinogen I and II were
measured blinded to case–control status using enzyme-linked
immunosorbent assays (Biohit, Helsinki, Finland). Aliquots from a
pool of serum samples of healthy individuals were distributed
among nine assay plates (two samples per plate). The coefficients
of variation were 8% and 14% for PGI and PGII, respectively.
H. pylori serology was evaluated qualitatively with western blot
assay (Helico Blot 2.1; MP Biomedicals Asia Pacific Ltd, Singapore,
Singapore). H. pylori infection was considered positive if (1) both
19.5- and 30-kDa bands were present or (2) any of the 35-, 37-, or
89-kDa band was present. CagA was positive if 116-kDa band was
present. We have carried out a validation study in the same
population with similar ethnic structure among 309 endoscopy
clinic patients and compared pepsinogen serology with histology
using modified Sydney classification as the gold standard. We
reported PGIo55 mg l 1 (sensitivity: 61.9%, specificity: 94.8%) as
the optimal cutoff point for serological diagnosis of gastric
fundal atrophy in the study population. At cutoff concentration
of 11.8mg l 1, PGII demonstrated 84.2% sensitivity and 45.4%
specificity to distinguish nonatrophic pangastritis (Nasrollahzadeh
et al, 2011).
Statistical methods
Serum PGI and PGII were analysed as dichotomous variables using
validated cutoff points. There was no a priori DMFT cutoff value,
and cubic spline curve did not highlight any specific pattern,
therefore the median DMFT was considered as a cutoff value for
dichotomising it. Conditional logistic regression models were used
to calculate odds ratios (ORs) and 95% confidence intervals (CIs).
In design, case and control subjects were individually matched for
age, sex, and place of residence. ORs were further adjusted for
education, ethnicity (Turkmen vs non-Turkmen), tobacco and
opium use, alcohol drinking, and fruit/vegetable consumption.
Interaction on additive scale between dichotomous variables of
gastric atrophy and poor dental health or oral hygiene habit was
evaluated and the relative excess risk due to interaction (RERI),
attributable proportion and synergy index were calculated. Delta
method was applied to calculate 95% CI for measures of
interaction. To address the effect of bias due to measurement
error in serology assay, the ORs adjusted for misclassification as a
function of different sensitivity and specificity for cases and
controls were calculated using external validation data. Two-sided
P-values p0.05 were considered as statistically significant. All
analyses were done using Stata version 11.1 (StataCorp., College
Station, TX, USA).
Ethical approval
This study was approved by the ethical committee of the Digestive
Disease Research Centre of Tehran University of Medical Sciences,
Iran, the Institutional Review Board of National Cancer Institute,
USA, and the Stockholm Regional Ethics Vetting Board, Sweden.
RESULTS
The study included 300 incident case patients and 571 matched
control subjects from whom serum samples were available for
293 (98%) cases and 524 (92%) controls. All cases had at least one
matched control. Demographic characteristics of the study
participants and potential confounders are summarised in
Table 1. No substantial differences were observed between those
who provided serum and those whose serum samples were not
available.
Table 2 demonstrates proportion of subjects with serological
gastric atrophy and ORs for association of PGI and PGII with
OSCC risk after further controlling for education level and
ethnicity (as socioeconomic index), opium and tobacco use, fruit,
vegetable, and alcohol consumption. A PGI o55 mg l 1 was
associated with a 1.39-fold increased risk of OSCC (95% CI: 0.93,
2.09). Histological diagnosis of non-atrophic gastritis was found in
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30% of OSCC cases with 2-fold risk comparing clinic controls
(OR¼ 1.97, 95% CI: 1.13, 3.45) (Supplementary Table). Because
gastritis might be caused secondary to OSCC, we evaluated the
association of gastric fundal atrophy with OSCC in combination
with severe nonatrophic pangastritis. Combination of PGI
o55 mg l 1 and PGII o11.8mg l 1 was associated with a two-fold
increased risk for OSCC. Further adjustment for tea-drinking habit
as a suggested strong risk factor in this population (Islami et al,
2009) did not alter the observed estimates. H. pylori serology,
measured as antibodies against either whole H. pylori or CagA, was
not associated with OSCC risk.
We applied other published thresholds for atrophy, including
PGIo30 mg l 1, PGI/PGII ratioo3 and PGIo70 mg l 1, PGI/PGII
ratio o3. The measures of association did not change materially.
Combination with PGII also showed similar results (Table 3).
Table 4 presents the results of joint effect of gastric atrophy,
poor dental health, and oral hygiene habit on OSCC risk after
breaking the matching factors. Adjusted OR for association of
DMFT with OSCC was 1.60 (95% CI: 1.14, 2.24). Although based
on modest numbers of cases, presence of poor dental hygiene,
indicated as higher than median DMFT, and gastric atrophy
rendered a more than four-fold excess risk of OSCC compared with
the group with neither poor dental hygiene nor atrophy. The RERI
between low DMFT and atrophy was 1.47 (95% CI:  1.15, 4.1),
synergy index (95% CI) 1.90 (0.6, 6.1), and the attributable
proportion (95% CI) 0.36 ( 0.14, 0.85). We used frequency of
tooth brushing as another measure of dental and oral hygiene in
combination with gastric atrophy, which resulted in an eight-fold
increase in OSCC risk (OR: 8.65, 95% CI: 3.65, 20.46) compared
with non-atrophic group who occasionally or regularly brush their
teeth. The RERI between habit of never brushing teeth and atrophy
was 4.34 (95% CI:  1.07, 9.76), synergy index 2.24 (95% CI: 0.97,
5.15), and attributable proportion 0.49 (95% CI: 0.14, 0.83).
Although based on fewer sets, conditional logistic regression
model showed similar results (data not shown).
To quantify the magnitude of misclassification bias that occurs
in presence of nonatrophic gastritis, we estimated the classification
probabilities using external validation study (Nasrollahzadeh et al,
2011). Effects of the range of PGII levels on diagnostic accuracy
of atrophy and corrected ORs for the association with OSCC are
Table 1 Characteristics of OSCC cases and matched controls, Golestan province, Iran, 2003–2007
Characteristics Cases (n¼ 293) Controls (n¼ 524) P-value
Controls without
serum samples (n¼ 47) P-valuea
Mean age (s.d.), years 64.4 (11.1) 65.5 (10.4) 0.95 62.1 (9.9) 0.07
Sex (%)
Men 147 (50.2) 256 (48.8) 0.71 22 (46.8) 0.8
Women 146 (49.8) 268 (51.2) 25 (53.2)
Residence area (%)
Urban 80 (27.3) 133 (25.4) 0.54 17 (36.2) 0.1
Rural 213 (72.7) 391 (74.6) 30 (63.8)
Ethnicity (%)
Turkmen 166 (56.7) 282 (53.8) 0.43 30 (63.8) 0.18
Non-Turkmen 127 (43.3) 242 (46.2) 17 (36.2)
Education (%)
Illiterate 261 (89.1) 437 (83.4) 0.02 37 (87.7) 0.41
Primary school and higher 32 (10.9) 87 (16.6) 10 (21.3)
Alcohol ever use (%)
No 287 (98) 511 (97.5) 0.69 46 (97.9) 0.88
Yes 6 (2) 13 (2.5) 1 (2.1)
Tobacco and opium useb (%)
Neither 162 (55.5) 366 (70.0) 0.0002 32 (68.1) 0.58
Ever use tobacco 43 (14.7) 59 (11.3) 7 (14.9)
Ever use opium 29 (10.0) 33 (6.3) 1 (2.1)
Ever use tobacco and opium 58 (19.8) 65 (12.4) 7 (14.9)
Fruit and vegetable consumption (%)
p Medianc 139 (47.4) 235 (44.8) 0.47 20 (42.5) 0.76
4 Median 154 (52.6) 289 (55.1) 27 (57.5)
DMFT (%)b
p Median (28) 117 (40.3) 266 (51.0) 0.004 28 (59.6) 0.25
4 Median 173 (59.7) 256 (49.0) 19 (40.4)
Tooth brushing habitb
Ever 59 (20.3) 221 (42.4) o0.0001 18 (39.1) 0.66
Never 232 (79.7) 300 (57.6) 28 (60.9)
PGI (mg l 1), median (IQR) 109.3 (67.2–147.5) 94.9 (66.6–123.3) NA
PGII (mg l 1), median (IQR) 14.2 (9.6–21.5) 12.3 (8.8–18.2) NA
PGI/PGII ratio, median (IQR) 7.0 (4.8–9.7) 7.2 (5.3–9.9) NA
Abbreviations: DMFT¼ Sum of decayed, missed, and filled teeth; IQR¼ interquartile range; NA¼ not applicable; OSCC¼ oesophageal squamous cell carcinoma. aP-value for
significance of difference between controls with and without serum samples. bNumbers of cases and controls were less than total because of missed data. cMedian fruit and
vegetable consumption¼ 521.8 gr/day.
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presented in Table 5. Differential misclassification of gastric
atrophy for cut points with low specificity (o80%) was far from
the null. When exposure detection was better among controls,
the resulted OR was extensively biased.
DISCUSSION
In this study, gastric atrophy, as indicated by low serum
pepsinogen, was associated with an increased risk of OSCC.
Table 2 Levels of pepsinogen I, pepsinogen II, and H. pylori serology and their associations with OSCC risk, Golestan province, Iran, 2003–2007
Controls, N (%) Cases, N (%) Crude OR (95% CI) Adjusted OR (95% CI)a
PGI (mg l 1)
X 55 449 (85.7) 238 (81.2) Referent Referent
o 55 75 (14.3) 55 (18.8) 1.33 (0.89–1.97) 1.39 (0.93–2.09)
PGIIb (mg l 1)
o11.8 246 (46.9) 113 (38.7) Referent Referent
X 11.8 278 (53.1) 179 (63.1) 1.37 (1.01–1.85) 1.40 (1.01–1.92)
PGI and PGIIb (mg l 1)
PGI X55 and PGIIo11.8 189 (36.1) 71 (24.2) Referent Referent
PGI o55 and PGII o11.8 57 (10.9) 42 (14.3) 1.92 (1.15–3.22) 2.01 (1.18–3.45)
PGI X55 and PGII X11.8 260 (49.6) 167 (57) Referent Referent
PGIo55 and PGII X11.8 18 (3.4) 12 (4.4) 1.02 (0.47–2.23) 1.20 (0.54–2.66)
H. pylori status
H. pylori cagA 52 (10) 35 (12) Referent Referent
H. pyloriþ cagA 34 (6.5) 14 (4.8) 0.64 (0.30–1.35) 0.70 (0.32–1.53)
H. pyloriþ cagAþ 351 (67.2) 179 (61.3) 0.73 (0.46–1.17) 0.79 (0.48–1.29)
H. pylori cagAþ 85 (16.3) 64 (21.9) 1.05 (0.60–1.85) 1.15 (0.63–2.08)
Abbreviations: cagA¼ cytotoxin-associated gene A; CI¼ confidence interval; H. pylori¼Helicobacter pylori; OR¼ odds ratio; OSCC¼ oesophageal squamous cell carcinoma;
PGI¼ pepsinogen I; PGII¼ pepsinogen II. aAdjusted for ethnicity (Non-Turkmen or Turkmen), alcohol consumption (never or ever), tobacco or opium use (none, only tobacco,
only opium, or both), education level (illiterate, primary school or more), and vegetable/fruit consumption. bFor one case, PGII level was missing and just PGI level was available.
Table 3 Gastric atrophy defined by other serology criteria in literature and its association with OSCC risk
Controls, N (%) Cases, N (%) Adjusted OR (95% CI)a
PGI
PGI X30 500 (95.4) 274 (93.5) Referent
PGI o30 24 (4.6) 19 (6.5) 1.52 (0.79–2.93)
Stratifying by PGII levelb
PGI X30 and PGIIo11.8 226 (43.1) 97 (33.1) Referent
PGI o30 and PGII o11.8 4 (0.8) 3 (1.0) 1.94 (0.91–4.13)
PGI X30 and PGII X11.8 274 (52.3) 176 (60.4) Referent
PGI o30 and PGII X11.8 20 (3.8) 16 (5.5) 1.10 (0.23–5.17)
PGI/PGII ratiob
Ratio X3 490 (93.5) 265 (90.8) Referent
Ratio o3 34 (6.5) 27 (9.2) 1.50 (0.85–2.60)
Stratifying by PGII levelb
Ratio X3 and PGII o11.8 233 (44.5) 100 (34.1) Referent
Ratio o3 and PGII o11.8 21 (4.0) 14 (4.8) 2.32 (1.00–5.39)
Ratio X3 and PGII X11.8 257 (49.0) 165 (56.7) Referent
Ratioo30 and PGII X11.8 13 (2.5) 13 (4.4) 1.03 (0.49–2.20)
PGI and PGI/PGII ratiob
PGI X70 or ratio X3 497 (94.9) 267 (91.5) Referent
PGI o70 and ratio o3 27 (5.1) 25 (8.5) 1.69 (0.93–3.10)
Stratifying by PGII levelb
(PGI X70 or ratio X3) and PGII o11.8 233 (44.5) 100 (34.19) Referent
(PGI o70 and ratio o3) and PGII o11.8 14 (2.6) 12 (4.1) 2.31 (0.99–5.38)
(PGI X70 or ratio X3) and PGII X11.8 264 (50.4) 167 (57.4) Referent
(PGI o70 and ratio o3) and PGII X11.8 13 (2.5) 13 (4.4) 1.24 (0.52–2.94)
Abbreviations: CI¼ confidence interval; OR¼ odds ratio; OSCC¼ oesophageal squamous cell carcinoma; PGI¼ pepsinogen I; PGII¼ pepsinogen II. aAdjusted for ethnicity
(Non-Turkmen or Turkmen), alcohol consumption (never or ever), tobacco or opium use (none, only tobacco, only opium, or both), education level (illiterate, primary school or
more), and vegetable/fruit consumption. bFor one case, PGII level was missing and just PGI level was available.
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Pepsinogens are markers of mixed conditions, including
gastritis and atrophy (He et al, 2011), which could be of distinct
etiologies in cancer patients. In spite of observed association
between serological nonatrophic pangastritis with OSCC in our
study, the probability of developing gastritis secondary to
oesophageal cancer is not ignorable because of several evidences.
Most importantly, studies with cohort design did not detect
significant association between PGII and OSCC risk. In addition,
cancer patients may develop gastritis due to non-steroidal anti-
inflammatory drug (NSAID) use, opportunistic infections in
stomach (cytomegalovirus, Epstein–Barr virus), malnutrition,
anaemia, and consequent use of iron tablets (Abraham et al,
1999; Lauwers et al, 2010). Stage of tumours in most of our study
population were III or IV at the time of diagnosis, and dysphagia
was the presenting symptom, which led to high proportion of
NSAID consumption among cases compared with controls
(24.7% vs 15.8%, P¼ 0.001). On the other hand, development of
marked atrophy needs long time period (Adamu et al, 2011) and
its initiation during OSCC progression with short lead time is
unlikely. Thus, in studying the relationship between
gastric atrophy and OSCC when serum collection period is close
to cancer diagnosis, PGI provides more valid estimate than
PGI/PGII ratio.
Low sensitivity for atrophy detection might lead to loss of
precision and power by unnecessarily reducing the exposed sample
size. We chose atrophy cutoff point at high specificity level (97%)
however, false negative probability of 0.4 and low prevalence of
gastric atrophy could potentially result in misclassification of
exposure among cases and controls. Which we believe, if evolves,
would be differential.
Histology is the gold standard for atrophy diagnosis, however,
detection of atrophy is difficult because of the limitation in
number of biopsies and patchy nature of atrophy. Furthermore,
mucosal inflammation and separation of glands by inflammatory
infiltrate would add more diagnostic difficulties in severe gastritis
(Owen, 2003). Because inflammation among our cancer patients
was more probable than healthy controls, the error probabilities
for unexposed cases and controls might not be identical. To
decrease the effect of mixed category and to reduce the problem of
non-identical false-negative probabilities, we stratified the pre-
sence of nonatrophic pangastritis and observed a two-fold
increased OSCC risk associated with atrophy.
Notably, reducing interpretations to a dichotomy could degrade
the information. False-negative results are inherent in serological
diagnosis of atrophy due to the low sensitivity of the diagnostic
method. It is believed that resulted misclassification will drive the
Table 4 Combined effects of gastric atrophy and dental health or oral hygiene habit on OSCC risk after breaking the matching factors
Gastric atrophy Gastric atrophy þ
Case/control ORa (95% CI) Case/control ORa (95% CI)
DMFT p28 29/104 Referent 12/26 1.65 (0.74–3.67)
P¼ 0.20
DMFT 428 40/84 1.71 (0.98–2.98) 30/31 3.47 (1.81–6.64)
P¼ 0.06 P o0.001
Ever tooth brushing 14/87 Referent 5/24 1.40 (0.44–4.39)
P¼ 0.57
Never tooth brushing 57/100 4.12 (2.05–8.28) 37/33 8.77 (3.89–19.72)
P o0.001 P o0.001
Abbreviations: CI¼ confidence interval; DMFT¼ sum of decayed, missed, and filled teeth; OR¼ odds ratio; OSCC¼ oesophageal squamous cell carcinoma. Measure of
interaction on additive scale: relative excess risk due to interaction with low DMFT (95% CI): 1.47 (1.15 to 4.1) and with never tooth brushing habit (95% CI): 4.34
(1.07 to 9.76). Measure of interaction on multiplicative scale: between atrophy and low DMFT: OR (95% CI): 1.44 (0.63–3.32); P¼ 0.39 and measure of interaction between
atrophy and never tooth brushing on multiplicative scale: OR (95% CI): 1.78 (0.30–10.42); P¼ 0.52. aORs (95% CI) levels adjusted for age, sex, residence area, ethnicity
(Non-Turkmen or Turkmen), alcohol consumption (never or ever), tobacco or opium use (none, only tobacco, only opium, or both), education level (illiterate, primary school or
more), and vegetable/fruit consumption.
Table 5 Gastric atrophy defined by PGI o55mg l 1 and its association with OSCC risk under assumption of various sensitivity (se) and specificity (sp)
among cases and controls
Controls
All PGII Only PGII o5 Only PGII o11.8 Only PGII o15 Only PGII o19 Only PGII o30 Only PGII 411.8
Se: 0.62 0.99 0.83 0.80 0.80 0.76 0.37
Sp: 0.95 0.68 0.89 0.91 0.92 0.94 0.98
Cases Se Sp
All PGII 0.62 0.95 1.63 a 6.6 3.9 3.3 2.4 0.59
Only PGII o5 0.99 0.68 a 0.79 a a a a a
Only PGII o11.8 0.83 0.89 0.6 a 2.5 1.5 1.3 0.9 0.2
Only PGII o15 0.80 0.91 0.8 a 3.3 1.97 1.7 1.2 0.3
Only PGII o19 0.80 0.92 0.9 a 3.6 2.2 1.83 1.3 0.3
Only PGII o30 0.76 0.94 1.1 a 4.6 2.8 2.3 1.65 1.66
Only PGII 411.8 0.37 0.98 4.7 a 19.1 11.4 9.6 6.8 1.69
Abbreviations: OSCC¼ oesophageal squamous cell carcinoma; PGI¼ pepsinogen I; PGII¼ pepsinogen II. ORs are adjusted for age, sex, and residence area in unconditional
logistic regression model. aThese cells yielded negative adjusted counts, which were impossible values for true counts, thus corrected ORs could not be estimated.
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association toward null if non-differential assumptions are met.
However, atrophy is an uncommon exposure and its binary value
is the result of categorising continuous PGI variable. Therefore,
we performed a sensitivity analysis with the external validation
data. Our results confirmed that the effect of misclassification due
to ignoring nonatrophic pangastritis on association between
atrophy and OSCC was substantial. This finding suggests that
PGII as a marker of severe inflammation could be used as a
stratifying factor.
In this study, we could not detect any association between
infection with cagA-positive H. pylori strains and OSCC risk, which
is in contrast to the results from the study among low-risk Swedish
population (Ye et al, 2004), Japanese alcoholic males (Yokoyama
et al, 2009), and in accordance to the reports from studies in
Linxian of China (Kamangar et al, 2007), Magdeburg of Germany
(Venerito et al, 2011), and among Finnish male smokers (Cook
et al, 2010). Spontaneous disappearance of H. pylori over time or
H. pylori eradication is possibly common in endemic areas.
Acquired immunodeficiency among advanced malnourished
cancer patients could be another explanation for reduced immune
response to antigens. These possibilities could lead to hetero-
geneity of H. pylori-negative category as a reference. Hence, our
risk estimates for H. pylori and CagA infection are inconclusive
because of difficulties in achieving a clean reference group in an
endemic area for H. pylori infection and among aged population in
a case–control design.
Our study might indicate areas to search for the underlying
mechanism. There was a suggestive evidence that the estimated
joint effect of poor dental health or never tooth brushing and
gastric atrophy together was larger than the sum of their effects
alone, which is in favour of the hypothesis of the bacterial
overgrowth in atrophic stomach and low-hygiene periodontal
mucosa (Meurman and Bascones-Martinez, 2011). Endogenous
formation of nitrosamines in the oral cavity of those with poor oral
hygiene is eightfold higher than that in those with good oral
hygiene (Nair et al, 1996). Upstream microbial community
members from the oral mucosa and oesophagus have the potential
to translocate to the stomach, and they might act as reservoirs for
recolonisation. Gastric microbiota shows considerable overlap
with oral microbiota (Bik et al, 2006), however, the mechanism of
these two bacterial environment in OSCC carcinogenesis could be
different. Our statistical inference on the presence of interaction
between poor oral hygiene and gastric atrophy has less precision
than the main finding of the study because of the modest sample
size. The observed interaction might be due to other mechanisms,
as tooth loss may be an indicator of a less healthy life style.
However, we did not detect association between education as a
socioeconomic status indicator and DMFT in our data. Also, low
DMFT could be a marker for distinct diet because of reduced
masticatory ability, hence, the detected association might be due to
residual confounding.
This study was a population-based study, matching improved
statistical efficiency, and sample size was the largest among the
studies so far published. Markers of the main exposure and
confounders were validated and extensive information on cofoun-
ders was available.
In conclusion, our population-based case–control study con-
firms that gastric atrophy is a risk factor for OSCC in high-risk
area of northern Iran. Excluding nonatrophic pangastritis through
stratifying by PGII level decreases the possibility of PGI
misclassification due to cancer-induced inflammation. Gastric
atrophy and poor oral hygiene may act synergistically in increasing
the risk of OSCC.
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